Though it is not possible to draw definitive conclusions from this evidence, it is likely that a more in-depth understanding of the functions of motilin in gut–brain signaling, both in healthy subjects and in patients with depression, would emerge from further human and animal studies. This evidence concerns the gene MLN and depressive symptom measurement.